Maria Repollés-De-Dalmau

Maria Repollés-De-Dalmau

Auto-generated profile, based on publicly available information

Maria Repollés-De-Dalmau

Institut de Recerca Biomèdica Catalunya Sud (formerly Institut d’Investigació Sanitària Pere Virgili), Hospital Universitari Joan XXIII, Tarragona 43005, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JSJoan Sabadell-Basallote
Joan Sabadell-Basallote
BABrenno Astiarraga
Brenno Astiarraga
CCCarlos Castaño
Carlos Castaño
MEMiriam Ejarque
Miriam Ejarque
MRMaria Repollés-De-Dalmau
Maria Repollés-De-Dalmau
SFSonia Fernández-Veledo
Sonia Fernández-Veledo
Pancreatic β cell dysfunction is a key feature of type 2 diabetes, and novel regulators of insulin secretion are desirable. Here, we report that succinate receptor 1 (SUCNR1) is expressed in β cells and is upregulated in hyperglycemic states in mice and humans. We found that succinate acted as a hormone-like metabolite and stimulated insulin secretion via a SUCNR1-Gq-PKC–dependent mechanism in human β cells. Mice with β cell–specific Sucnr1 deficiency exhibited impaired glucose tolerance and insulin secretion on a high-fat diet, indicating that SUCNR1 is essential for preserving insulin secretion in diet-induced insulin resistance. Patients with impaired glucose tolerance showed an enhanced nutrition-related succinate response, which correlates with the potentiation of insulin secretion during intravenous glucose administration. These data demonstrate that the succinate/SUCNR1 axis is activated by high glucose and identify a GPCR-mediated amplifying pathway for insulin secretion relevant to the hyperinsulinemia of prediabetic states.

12 June 2026 in Science Advances
Verified
Journal Article
Open access
AMAnna Marsal-Beltran
Anna Marsal-Beltran
LSLaura Salmerón-Pelado
Laura Salmerón-Pelado
ARAleix Ribas-Latre
Aleix Ribas-Latre
MRMaria Repollés-De-Dalmau
Maria Repollés-De-Dalmau
MRM-Mar Rodríguez-Peña
M-Mar Rodríguez-Peña
SFSonia Fernández-Veledo
Sonia Fernández-Veledo
Succinate, a mitochondrial metabolite, also functions as an extracellular signal through its receptor succinate receptor 1 (SUCNR1), coordinating responses to nutrient availability. The physiological role of SUCNR1 within hepatocytes, however, is unclear. We show that hepatic succinate levels and Sucnr1 expression are dynamically regulated by nutritional status. Mice lacking Sucnr1 in hepatocytes [Hep- Sucnr1 knockout (KO)] exhibit a fasting-like phenotype characterized by enhanced gluconeogenesis, elevated amino acids, and impaired metabolic flexibility. Mechanistically, loss of Sucnr1 compromises glucose-derived oxidative flux through the tricarboxylic acid cycle, increases reliance on glutamine-dependent anaplerosis, and induces mitochondrial stress adaptations. Upon refeeding, Hep- Sucnr1 KO mice show blunted mammalian target of rapamycin activation, incomplete glycogen restoration, and an altered hepatic proteomic response. Sucnr1 expression increases during liver maturation, is enriched in pericentral hepatocytes, and its loss is associated with functional reprogramming of pericentral metabolic functions without disruption of zonation. Together, our findings establish SUCNR1 as a critical regulator of hepatic metabolic adaptation, linking succinate signaling to mitochondrial flexibility and nutrient-dependent metabolic responses.